Curis, Inc. (CRIS)
0.5499
+0.02
(+3.17%)
USD |
NASDAQ |
Apr 02, 16:00
0.55
0.00 (0.00%)
After-Hours: 20:00
Curis EPS Diluted (Quarterly) : 1.229 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.301 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
| Viskase Holdings, Inc. | -2.159 |
| Halozyme Therapeutics, Inc. | -1.203 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.36M |
| Revenue (Quarterly) | 1.138M |
| Total Expenses (Quarterly) | -18.22M |
| Enterprise Value | 18.54M |
| Gross Profit Margin (Quarterly) | 96.84% |
| Earnings Yield | -210.4% |
| Normalized Earnings Yield | -423.43 |